In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals affected with NT5C2-related conditions. This variant is present in population databases (rs751199209, gnomAD 0.004%). This sequence change disrupts the translational stop signal of the NT5C2 mRNA. It is expected to extend the length of the NT5C2 protein by 2 additional amino acid residues.
ClinVar Genomic variation as it relates to human health
NM_001351169.2(NT5C2):c.1665GGA[7] (p.Glu561_Ter562insGluGlu)
Germline
Classification
Help
The aggregate germline classification for this variant, typically for a monogenic or Mendelian disorder as in the ACMG/AMP guidelines, or for response to a drug. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the aggregate classification.
(1)
Help
Stars represent the aggregate review status, or the level of review supporting the aggregate germline classification for this VCV record. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. The number of submissions which contribute to this review status is shown in parentheses.
Uncertain significance
1
criteria provided, single submitter
Somatic
No data submitted for somatic clinical impact
Somatic
No data submitted for oncogenicity
Variant Details
- Identifiers
-
NM_001351169.2(NT5C2):c.1665GGA[7] (p.Glu561_Ter562insGluGlu)
Variation ID: 2062772 Accession: VCV002062772.2
- Type and length
-
Microsatellite, 6 bp
- Location
-
Cytogenetic: 10q24.32 10: 103089678-103089679 (GRCh38) [ NCBI UCSC ] 10: 104849435-104849436 (GRCh37) [ NCBI UCSC ]
- Timeline in ClinVar
-
First in ClinVar Help The date this variant first appeared in ClinVar with each type of classification.
Last submission Help The date of the most recent submission for each type of classification for this variant.
Last evaluated Help The most recent date that a submitter evaluated this variant for each type of classification.
Germline Feb 8, 2023 Feb 14, 2024 Dec 6, 2022 - HGVS
-
... more HGVS ... less HGVSNucleotide Protein Molecular
consequenceNM_001351169.2:c.1665GGA[7] MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
NP_001338098.1:p.Glu561_Ter562insGluGlu inframe insertion NM_017649.5:c.*12501CTC[7] MANE Select Help Transcripts from the Matched Annotation from the NCBI and EMBL-EBI (MANE) collaboration.
3 prime UTR NM_001134373.3:c.1665GGA[7] NP_001127845.1:p.Glu561_Ter562insGluGlu inframe insertion NM_001351170.2:c.1689GGA[7] NP_001338099.1:p.Glu569_Ter570insGluGlu inframe insertion NM_001351171.2:c.1689GGA[7] NP_001338100.1:p.Glu569_Ter570insGluGlu inframe insertion NM_001351172.2:c.1689GGA[7] NP_001338101.1:p.Glu569_Ter570insGluGlu inframe insertion NM_001351173.2:c.1689GGA[7] NP_001338102.1:p.Glu569_Ter570insGluGlu inframe insertion NM_001351174.1:c.1578GGA[7] NP_001338103.1:p.Glu532_Ter533insGluGlu inframe insertion NM_001351175.2:c.1572GGA[7] NP_001338104.1:p.Glu530_Ter531insGluGlu inframe insertion NM_001351176.2:c.1092GGA[7] NP_001338105.1:p.Glu370_Ter371insGluGlu inframe insertion NM_001351177.2:c.1092GGA[7] NP_001338106.1:p.Glu370_Ter371insGluGlu inframe insertion NM_001351178.2:c.1092GGA[7] NP_001338107.1:p.Glu370_Ter371insGluGlu inframe insertion NM_001351179.2:c.1092GGA[7] NP_001338108.1:p.Glu370_Ter371insGluGlu inframe insertion NM_001351180.2:c.1092GGA[7] NP_001338109.1:p.Glu370_Ter371insGluGlu inframe insertion NM_001351181.2:c.1092GGA[7] NP_001338110.1:p.Glu370_Ter371insGluGlu inframe insertion NM_001351182.2:c.1092GGA[7] NP_001338111.1:p.Glu370_Ter371insGluGlu inframe insertion NM_001351183.2:c.1092GGA[7] NP_001338112.1:p.Glu370_Ter371insGluGlu inframe insertion NM_001351184.2:c.1092GGA[7] NP_001338113.1:p.Glu370_Ter371insGluGlu inframe insertion NM_001351185.2:c.1092GGA[7] NP_001338114.1:p.Glu370_Ter371insGluGlu inframe insertion NM_001351186.2:c.1092GGA[7] NP_001338115.1:p.Glu370_Ter371insGluGlu inframe insertion NM_001351187.2:c.1092GGA[7] NP_001338116.1:p.Glu370_Ter371insGluGlu inframe insertion NM_001351188.2:c.1092GGA[7] NP_001338117.1:p.Glu370_Ter371insGluGlu inframe insertion NM_001351189.2:c.1092GGA[7] NP_001338118.1:p.Glu370_Ter371insGluGlu inframe insertion NM_001351190.2:c.1092GGA[7] NP_001338119.1:p.Glu370_Ter371insGluGlu inframe insertion NM_001351191.1:c.1092GGA[7] NP_001338120.1:p.Glu370_Ter371insGluGlu inframe insertion NM_001351192.1:c.1092GGA[7] NP_001338121.1:p.Glu370_Ter371insGluGlu inframe insertion NM_001351193.1:c.1092GGA[7] NP_001338122.1:p.Glu370_Ter371insGluGlu inframe insertion NM_001351194.2:c.951GGA[7] NP_001338123.1:p.Glu323_Ter324insGluGlu inframe insertion NM_001351195.2:c.951GGA[7] NP_001338124.1:p.Glu323_Ter324insGluGlu inframe insertion NM_001351196.2:c.951GGA[7] NP_001338125.1:p.Glu323_Ter324insGluGlu inframe insertion NM_001351197.2:c.1092GGA[7] NP_001338126.1:p.Glu370_Ter371insGluGlu inframe insertion NM_012229.5:c.1665GGA[7] NP_036361.1:p.Glu561_Ter562insGluGlu inframe insertion NM_199076.3:c.*12501CTC[7] 3 prime UTR NC_000010.11:g.103089681CTC[7] NC_000010.10:g.104849438CTC[7] NG_031932.2:g.176389CTC[7] NG_042272.1:g.108614GGA[7] - Protein change
- -
- Other names
- -
- Canonical SPDI
- NC_000010.11:103089678:TCCTCCTCCTCCTCCTC:TCCTCCTCCTCCTCCTCCTCCTC
-
Functional
consequence HelpThe effect of the variant on RNA or protein function, based on experimental evidence from submitters.
- -
-
Global minor allele
frequency (GMAF) HelpThe global minor allele frequency calculated by the 1000 Genomes Project. The minor allele at this location is indicated in parentheses and may be different from the allele represented by this VCV record.
- -
-
Allele frequency
Help
The frequency of the allele represented by this VCV record.
- -
- Links
Genes
| Gene | OMIM | ClinGen Gene Dosage Sensitivity Curation |
Variation Viewer
Help
Links to Variation Viewer, a genome browser to view variation data from NCBI databases. |
Related variants | ||
|---|---|---|---|---|---|---|
| HI score
Help
The haploinsufficiency score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
TS score
Help
The triplosensitivity score for the gene, curated by ClinGen’s Dosage Sensitivity Curation task team. |
Within gene
Help
The number of variants in ClinVar that are contained within this gene, with a link to view the list of variants. |
All
Help
The number of variants in ClinVar for this gene, including smaller variants within the gene and larger CNVs that overlap or fully contain the gene. |
|||
| CNNM2 | - | - |
GRCh38 GRCh37 |
318 | 396 | |
| NT5C2 | - | - |
GRCh38 GRCh37 |
204 | 267 | |
Conditions - Germline
| Condition
Help
The condition for this variant-condition (RCV) record in ClinVar. |
Classification
Help
The aggregate germline classification for this variant-condition (RCV) record in ClinVar. The number of submissions that contribute to this aggregate classification is shown in parentheses. (# of submissions) |
Review status
Help
The aggregate review status for this variant-condition (RCV) record in ClinVar. This value is calculated by NCBI based on data from submitters. Read our rules for calculating the review status. |
Last evaluated
Help
The most recent date that a submitter evaluated this variant for the condition. |
Variation/condition record
Help
The RCV accession number, with most recent version number, for the variant-condition record, with a link to the RCV web page. |
|---|---|---|---|---|
| Uncertain significance (1) |
criteria provided, single submitter
|
Dec 6, 2022 | RCV002923658.3 |
Submissions - Germline
| Classification
Help
The submitted germline classification for each SCV record. (Last evaluated) |
Review status
Help
Stars represent the review status, or the level of review supporting the submitted (SCV) record. This value is calculated by NCBI based on data from the submitter. Read our rules for calculating the review status. This column also includes a link to the submitter’s assertion criteria if provided, and the collection method. (Assertion criteria) |
Condition
Help
The condition for the classification, provided by the submitter for this submitted (SCV) record. This column also includes the affected status and allele origin of individuals observed with this variant. |
Submitter
Help
The submitting organization for this submitted (SCV) record. This column also includes the SCV accession and version number, the date this SCV first appeared in ClinVar, and the date that this SCV was last updated in ClinVar. |
More information
Help
This column includes more information supporting the classification, including citations, the comment on classification, and detailed evidence provided as observations of the variant by the submitter. |
|
|---|---|---|---|---|---|
|
Uncertain significance
(Dec 06, 2022)
|
criteria provided, single submitter
Method: clinical testing
|
Hereditary spastic paraplegia 45
Affected status: unknown
Allele origin:
germline
|
Labcorp Genetics (formerly Invitae), Labcorp
Accession: SCV003272681.2
First in ClinVar: Feb 07, 2023 Last updated: Feb 14, 2024 |
Comment:
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant … (more)
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals affected with NT5C2-related conditions. This variant is present in population databases (rs751199209, gnomAD 0.004%). This sequence change disrupts the translational stop signal of the NT5C2 mRNA. It is expected to extend the length of the NT5C2 protein by 2 additional amino acid residues. (less)
|
Comment:
Germline Functional Evidence
| There is no functional evidence in ClinVar for this variation. If you have generated functional data for this variation, please consider submitting that data to ClinVar. |
Comment:
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals affected with NT5C2-related conditions. This variant is present in population databases (rs751199209, gnomAD 0.004%). This sequence change disrupts the translational stop signal of the NT5C2 mRNA. It is expected to extend the length of the NT5C2 protein by 2 additional amino acid residues.
Citations for germline classification of this variant
Help| There are no citations for germline classification of this variant in ClinVar. If you know of citations for this variation, please consider submitting that information to ClinVar. |
Text-mined citations for this variant ...
HelpRecord last updated Sep 29, 2024
This date represents the last time this VCV record was updated. The update may be due to an update to one of the included submitted records (SCVs), or due to an update that ClinVar made to the variant such as adding HGVS expressions or a rs number. So this date may be different from the date of the “most recent submission” reported at the top of this page.